期刊文献+

cyclinG2表达载体的构建及其对人胃癌细胞生长的作用

Construction of human cyclin G2 gene eukaryotic expression recombinant and it’s effect on the growth of human gastric carcinoma cell
下载PDF
导出
摘要 目的:构建包含人cyclinG2基因的真核表达载体,并探讨其对人胃癌细胞体外生长的作用。方法:从POE4细胞总RNA反转录产物中扩增出cyc-linG2cDNA,亚克隆至双顺反子真核表达载体pIRESneo中获得pIRES-G2重组质粒,基因转染SGC-7901细胞,G418筛选阳性克隆,免疫蛋白印迹杂交方法检测cyclinG2蛋白表达情况,平板克隆形成能力和四甲基噻唑蓝(MTT)比色法对转染后细胞的增殖活性进行分析。结果:成功构建包含cyclinG2基因真核重组表达载体pIRES-G2;转染pIRES-G2的SGC-7901细胞克隆的增殖活性明显下降。结论:cyclinG2基因转染后SGC-7901细胞体外增殖能力下降。 OBJECTIVE: To construct human cyclin G2 gene eukaryotic vector and study it's effect on human gastric carcinoma cell line growth in vitro. METHODS: The cyclin G2 cDNA fragment was amplified from the reverse transcription products of POE4 cell line by reverse polymerase chain reaction and subcloned into pIRESneo vector to build up recombinant expression plasmid pIRES-G2, identified by colony polymerase chain reaction and sequence analysis. Then it was transferred into SGC-7901cell by cation lipofectin reagent. Cell clones were chosen by G418 and enlarged to culture. The expression level of cyclin G2 protein was examined by using Western blot technique. Cell proliferation ability was tested by clone formation ability and MTT assay. RESULTS: cyclin G2 gene eukaryotic expression vector was constructed successfully, the proliferation ability of cyclin G2 gene transfection anti-clones was lower compared with control group. CONCLUSIONS: cyclin G2 gene could inhibit the growth of SGC-7901. It may be a negative regulator in gastric carcinoma cell cycle regulation.
出处 《中华肿瘤防治杂志》 CAS 2006年第5期335-338,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 教育部高等学校优秀青年教师教学科研奖励计划资助(教人司:2000-26)
关键词 细胞周期蛋白类 转染 胃肿瘤 基因 cyclins transfection stomach neoplasms gene
  • 相关文献

参考文献12

  • 1Tamura K,Kanaoka Y,Jinno S,et al.Cyclin G:a new mammalian Cyclin with homology to fission yeast Cigl[J].Oncogene,1993,8(8):113-118.
  • 2Jensen M R,Audolfsson T,Keck C L,et al.Gene structure and chromosomal localization of mouse Cyclin G2 (Ccng2)[J].Gene,1999,230(2):171-180.
  • 3HorneMC,DonaldsonKL,GoolsbyGL,et al.GyclinG2 is up-regulated during growth inhibition and B cell antigen receptor mediated cell cycle arrest[J].J Biol Chem,1997,272 (19):12650-12661.
  • 4Wykoff C C,Pugh C W,Maxwell P H,et al.Identification of novel hypoxia dependent and independent target genes of the yon Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling[J].Oncogene,2000,19(54):6297-6305.
  • 5Bates S,Rowan S,Vousden K H,et al.Characterisation of hu man Cyclin G1 and G2:DNA damage inducible genes[J].Oncogene,1996,13(5):1103-1109.
  • 6Yong K,Satoru S,Yohko K,et al.Cyclin G2 dysregulation in human oral cancer[J].Cancer Res,2004,64(24):8980-8986.
  • 7Alevizos I,Mahadevappa M,Zhang X,et al.Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis[J].Oncogene,2001,20 (43):6196-6204.
  • 8Ito Y,Yoshida H,Uruno T,et al.Decreased expression of Cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid[J].Anticancer Res,2003,23(3B):2335-2338.
  • 9Gaines P,Wojchowski D M.pIRES-CD4t,a dicistronic expression vector for MACS-or FACS based selection of transfected cells[J].Biotechniques,1999,26 (4):683-688.
  • 10Romano G,Micheli P,Pacilio C,et al.Latest developments ingene transfer technology:C achievements,perspectives,and controversies over therapeutic applications[J].Stem Cells,2000,18(1):19-39.

二级参考文献24

  • 1Litzinger D C,Brown J M,Wala L,et al. Fate of cationic liposomes and their complex with oligonucleotides in vivo[J].Biochim Biophys Acta,1996,1281(2):139-149.
  • 2Li S,Tseng W C,Stolz D B,et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection[J].Gene Ther,1999,6(4):585-594.
  • 3Sakurai F,Nishioka T,Saito H,et al. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice:the role of the neutral helper lipid[J].Gene Ther,2001,8(9):677-686.
  • 4Lee H,Jeong J H,Park T G. PEG grafted polylysine with fusogenic peptide for gene delivery:high transfection efficiency with low cytotoxicity[J].J Control Release,2002,79(1-3):283-291.
  • 5Kircheis R,Wightman L,Kursa M,et al. Tumor-targeted gene delivery:an attractive strategy to use highly active effector molecules in cancer treatment[J].Gene Therapy,2002,9(11):731-735.
  • 6Rapoport S I. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy[J].Expert Opin Investig Drugs,2001,10(10):1809-1818.
  • 7Kaneda Y. Improvements in gene therapy technologies[J].Mol Urol,2001,5(2):85-89.
  • 8Li X,Stuckert P. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells[J].Cancer Gene Ther,2001,8(8):555-565.
  • 9Safinya C R. Structures of lipid-DNA complexes:supramolecular assembly and gene delivery[J].Curr Opin Struc Biol,2001,11(4):440-448.
  • 10Kyriakides T R,Cheung C Y,Murthy N. pH-sensitive polymers that enhance intracellular drug delivery in vivo[J].J Control Release,2002,78(1-3):295-303.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部